john w kuo  varian medical systems language select united states  english china  simplified chinese  china  traditional chinese  united kingdom  english france  french français japan  japanese  australia  english search form navigation oncologyoverviewaboutoncology trendsour history  commitmentour missiongovernment affairsresearch grantssolutionsradiosurgeryradiotherapyproton therapymedical oncologybrachytherapyprofessional servicesproductstreatment deliverysoftwarecloudbased appsrealtime tracking  motion managementtreatment techniquesexternal beam radiationinternal radiation therapy brachytherapyparticle therapyservice  educationtreatment delivery servicesoftware supporteducation  traininginstallation  implementationinteroperabilityevents  resourcescenterlineeventswebinarsvarian unite appfor patientsproton therapyproductsprobeam® proton therapy systemprobeam® compact singleroom proton therapy solutionprobeam® multiroom proton therapy solutiontreatment techniquesimptigptspot on blogabout varianoverviewvarian technologiesleadership and governanceexecutivesboard of directorscitizenshipmission and valuesemployees and business partnersenvironmentgivingcareerslife at varianuniversity recruitingbenefitsinvestorsinvestor informationannual reportsstock informationpresentationsfinancialsnews  eventscorporate governancesocial responsibilityshareholder servicesinvestor contactsnewsroompress releasesimage gallerymedical resourcescareerslife at varianuniversity recruitingbenefitsmedical resourcesinvestorsinvestor informationannual reportsstock informationpresentationsfinancialsnews  eventscorporate governancesocial responsibilityshareholder servicesinvestor contactsnewsroompress releasesimage gallerycontact us english myvarian contact us newsroom investorsmedical resourcescareers oncology aboutsolutionsproductstreatment techniquesservice  educationevents  resourcesfor patientstreatment locator oncology trendsour history  commitmentour missiongovernment affairsresearch grants radiosurgeryradiotherapyproton therapymedical oncologybrachytherapyprofessional services treatment deliverysoftwarecloudbased appsrealtime tracking  motion management external beam radiation srssabr  sbrtimrtigrtvmat internal radiation therapy brachytherapy hdrldrigbtpdr particle therapy igptimpt treatment delivery service software support education  training installation  implementation interoperability ihe statementdicom conformance statements centerlineeventswebinarsvarian unite app for patients knowledge is strength visit varians patient information web site to learn more about your treatment options what to expect during treatment faqs and even patient stories all designed to help you make informed decisions that impact you or your loved ones in the fight against cancer treatment locator looking for hospitals and clinics that use varian technology use our treatment locator to find the centers closest to you proton therapy productstreatment techniquesspot on blog probeam® proton therapy system probeam® compact singleroom proton therapy solution probeam® multiroom proton therapy solution impt igpt spot on blog the spot on blog is a company blog about proton therapy for the treatment of cancer spot on blog will deliver information about new technology developments system deployments research and insights from clinicians about varian varian technologiesleadership and governancecitizenshipcareersinvestorsnewsroommedical resources varian technologies focusing energy on saving lives executives board of directors mission and values employees and business partners environment giving life at varian university recruiting benefits investor information annual reports stock information presentations financials news  events corporate governance social responsibility shareholder services investor contacts press releases image gallery medical resources engaging with clinicians around the world to exchange clinical information scientific research and expert opinion navigation navigation executive profile oncologyproton therapyabout variancareersmedical resourcesinvestorsnewsroomabout varianoverviewvarian technologiesleadership and governancecitizenshipcareersinvestorsnewsroommedical resourcesleadership and governanceexecutivesboard of directorsexecutives share john w kuo senior vice president general counsel and corporate secretary john w kuo was named corporate vice president general counsel and secretary for varian medical systems in  he joined the company as associate general counsel in  focusing in the areas of securities corporate governance and ma today his management responsibilities include the companys legal trade compliance environmental affairs and government affairs functions kuo is also the secretary to the companys board of directors prior to joining varian kuo held senior legal positions at several companies including broadvision com corporation and acer america he was also previously with the law firms of gray cary ware  freidenrich now dla piper and fulbright  jaworski kuo graduated from cornell university in  and earned his law degree from boalt hall uc berkeley in  he has been admitted to the state bars of california and texas he also serves on the law cabinet of the united way silicon valley and on the board of the boalt hall alumni association john w kuo  a palo alto california ca lawyer findlaw are you a legal professional visit our professional site law firm marketing updated your profile update now kuo john w varian medical systems inc  hansen waypalo alto ca  websites associated with this firmwwwvariancom phones    contact us when viewing a listing consider the state advertising restrictions to which lawyers and law firms must adhere as well as our west legal directory disclaimers some lawyers publish comparative information regarding the services that they provide which may be subject to specific comparative communications restrictions map location please enable javascript to view the map view larger mapdirections » how do i choose a lawyerconsider the following comfort level  are you comfortable telling the lawyer personal information does the lawyer seem interested in solving your problem credentials  how long has the lawyer been in practice has the lawyer worked on other cases similar to yours cost  how are the lawyers fees structured  hourly or flat fee can the lawyer estimate the cost of your case city  is the lawyers office conveniently located not sure what questions to ask a lawyerhere are a few to get you started how long have you been in practice how many cases like mine have you handled how often do you settle cases out of court what are your fees and costs what are the next steps want to check lawyer disciplineresearch lawyer discipline form  varian medical systems for may  filed by kuo john w research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  varian medical systems for may  filed by kuo john w by k wizard—  pm et  httparchivefastedgarcomahzzoqcsczuzrzzujuzzg filed on june   more var news elekta shares fall after big q earnings miss reuters   am et  four plead not guilty to insider trading involving us health agency reuters   pm et  experts present new radiosurgery techniques using varian technology for optimal targeting of multiple metastases pr newswire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  var stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsvar varian medical system    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all varian eclipse users generate highest scoring plans in international treatment plan competition pr newswire –  am et  palo alto calif the two highest scoring plans and seven of the top  plans at the competition were created using varians eclipse treatment planning software and employed volumetric arc therapy to target head and neck cancers congratulations to the top scorers in the  international radiotherapy plan competition said pat kupelian vice president of medical affairs at varian leading cancer center commences advanced treatments using varian edge™ radiosurgery system pr newswire –  am et  tbilisi georgia july   a yearold breast cancer patient has become the first person in the nation of georgia to be treated using the edge radiosurgery system from varian medical systems var in combination with respiratory gating varian medical systems receives fda k clearance for halcyon treatment system pr newswire –  am et  palo alto calif we are proud that halcyon has now received both  clearance and ce mark said kolleen kennedy president of varians oncology systems business halcyon is an advanced system that is more comfortable for the patient while delivering ease of use for healthcare providers accelerated installation timeframes expedited commissioning simplified training and automated treatment todays research report coverage on medical equipment stocks  prestige brands smith  nephew steris and varian medical systems pr newswire –  am et  new york june   if you want a stock review on pbh snn ste or var then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister prestige brands  on wednesday shares in tarrytown new york headquartered prestige brands holdings inc pbh recorded a trading volume of  thousand shares varian medical systems schedules third quarter fy news release and conference call pr newswire –  am et  palo alto calif for automatic email alerts regarding varian news and events investors can subscribe on the company website httpinvestorsvariancominvestoralerts about varian medical systemsvarian medical systems var focuses energy on saving lives and is the worlds leading manufacturer of medical devices and software for treating and managing cancer major milestone for uks first high energy proton therapy center with varian cyclotron installation pr newswire –  am et  the cyclotron is a core piece of equipment of varians probeam® system which is equipping the fourroom christie proton therapy center varian works with sify technologies to host data remotely across ctsi network of cancer centers in india pr newswire –  am et  hyderabad india june   in the first project of its kind outside the united states varian medical systems var is working with sify technologies to provide softwareasaservice to radiotherapy centers across india varian and national centre for particle therapy in denmark attain milestone with successful cyclotron installation pr newswire –  am et  palo alto calif the cyclotron is a particle accelerator which accelerates protons to two thirds of the speed of light for clinical use the installation of the cyclotron is a major milestone in this project and gets us closer to making this advanced cancer fighting technology available to patients in denmark said ole nørrevang chief physicist danish centre for particle therapy varian spotlights new halcyon radiotherapy treatment system at degro  pr newswire –  am et  berlin june   varian medical systems var is spotlighting its new halcyon radiotherapy treatment system at the  meeting of degro the german radiation oncology society which takes place in berlin from june thth in addition to this new treatment device varian will also be exhibiting its full range of solutions for radiotherapy radiosurgery brachytherapy and proton therapy briefvarian medical signs agreement with vijametech and upmc reuters –  am et  varian medical systems inc var  signed an agreement with vijametech and upmc to develop plans for future radiation oncology centers in vietnam  co vijametech upmc will be collaborating with ministry of health and vietnam national cancer hospital source text for eikon further company coverage varian joins partnership to develop radiotherapy centers in vietnam pr newswire –  am et  palo alto calif varian is proud to be part of this effort to expand the availability of advanced cancer fighting technologies and services in vietnam said dow wilson ceo of varian medical systems elekta shares fall after big q earnings miss reuters –  am et  swedish radiotherapy equipment maker elekta posted on thursday a surprise drop in fiscal fourthquarter core earnings and order intake fell far below forecasts sending shares sharply lower four plead not guilty to insider trading involving us health agency reuters –  pm et  a washington dc political consultant and three others pleaded not guilty on wednesday to charges that they engaged in an insider trading scheme based on leaks from within a federal healthcare agency experts present new radiosurgery techniques using varian technology for optimal targeting of multiple metastases pr newswire –  am et  palo alto calif as a gold sponsor of the th biennial isrs varian is featuring an industrysponsored session on may th that includes a handson presentation by the varian eclipse product management team preceded by a detailed presentation from glasgows beatson west  scotland cancer center on the validation of hyperarc high definition radiotherapy for multiple metastases five charged with insider trading involving us health agency reuters –  pm et  five men including a washington political consultant and a federal employee were criminally charged on wednesday with engaging in an insider trading scheme based on leaks from within a federal healthcare agency briefsec charges four in insider case linked to healthcare policy leaks reuters –  am et  us securities and exchange commission files civil insider trading case against david blaszczak jordan fogel theodore huber christopher worrall in connection with healthcare policy leaks  court papers sec charges were filed after criminal charges were unveiled against the four defendants as well as a fifth defendant robert olan sec says worrall a senior staff member at centers for medi varian selected to provide first proton therapy system in thailand pr newswire –  am et  palo alto calif the varian probeam compact system is the only singleroom system capable of fully rotational intensity modulated proton therapy research reports coverage on healthcare stocks  biocept varian medical systems hillrom and tivity health pr newswire –  am et  new york may   on tuesday the nasdaq composite ended the day at  up  the dow jones industrial average edged  higher to finish at  and the sp  closed at  marginally gaining  gains were broad based as five out of nine sectors finished the trading session in green httpstockcallerscomregistration briefvarian probeam proton therapy system receives shonin approval reuters –  am et  varian medical systems inc var  varian probeam proton therapy system receives shonin approval  varian medical systems received shonin approval from japanese ministry of health labor and welfare to market probeam system for proton therapy in japan source text for eikon further company coverage varian probeam proton therapy system receives shonin approval pr newswire –  am et  palo alto calif varians probeam system is the first to offer fullyintegrated intensity modulated proton therapy to enable more efficient adaptive proton therapy page page   next  todays and upcoming events jul  var to announce q earnings after market confirmed jul  var earnings conference call at  pm listen past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe john kuo  varian medical systems inc  zoominfocom track insider buy and sell kuo john w officer svp gen counsel and secretary of var  past performance as of  total  records link to thomson financial buyp sells ps date filed date company symbol insider relationship share amt unit price total proceeds shares owned returnm details s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary     na view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer svp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view s    varian medical systems inc var kuo john w officer vp gen counsel and secretary      view  filed by insider as open market transaction but marked as private transaction by insidercows proprietary method svp gen counsel and secretary of varian medical systems nysevar kuo john w sells  shares worth  stay connected latest posts in rss businessentertainmentfeatured newsfeatured press releasefinancehealthlifestylenationnon firstpageoriginalpress releasereviewshoppingsportsstockstechnologytravelworld latest comments in rss  empowerednews world news summary helping you stay informed business finance sports entertainment health technology travel shopping our writers about us privacy policy contact us advertise press releases svp gen counsel and secretary of varian medical systems nysevar kuo john w sells  shares worth  according to varian medical systemss most recent form  filing with the sec dated jul   pm company svp gen counsel and secretary kuo john w disclosed selling  shares at a cost of  at the time of this transaction jul  this trade was worth  in total as of jul  kuo john w now owns  shares in total worth about  for the last few recent trades made by varian medical systems nysevar svp gen counsel and secretary kuo john w we have the following information sec form  filing jul  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of jul  were  sec form  filing jun  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of jun  were  sec form  filing may  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of may  were  posted by george daniels on thursday july    pm edt all trademarks acknowledged filed under stocks comments closed trackbacks open follow responses rss  comments are closed latest news principal accounting officer of fulton financial corporation nasdaqfult deporter michael j sells  shares worth  evp sales  marketing of counterpath corporation nasdaqcpah carothers todd buys  shares worth  president  ceo of counterpath corporation nasdaqcpah jones donovan buys  shares worth  chief financial officer of counterpath corporation nasdaqcpah karp david buys  shares worth  director of bank of the james financial gro nasdaqbotj bryant william c iii buys  shares worth  director of bank of the james financial gro nasdaqbotj foster watt r jr buys  shares worth  director of bank of the james financial gro nasdaqbotj langley lydia k buys  shares worth  chairman of lightbridge corporation nasdaqltbr graham thomas jr buys  shares worth  chairman of the board ceo of commerce bancshares nasdaqcbsh kemper david w sells  shares worth  evpclocre of eagle bancorp nasdaqegbn marquez antonio f sells  shares worth  news categories business  stocks  entertainment  featured news  featured press release  finance  health  lifestyle  nation  non firstpage  original  press release  review  shopping  sports  technology  travel  world  featured press releases radiology oncology surgical robots market worth  billion by  power wheelchairs and personal mobility market worth  billion by  patient monitoring equipment market worth  billion by  surgical robots market worth  billion by  optical transceivers market worth  billion by  pvc cabinets sales global market analysis goldenhomekohler nobiliaoppein and forecast to  air cargo screening systems global market by competitive environment and resources analysis  water supply equipment global market industry price labor cost  economic environment analysis  water tank global market share by major manufacture  key manufacturers analysis  counterfeit money detection global market in major countries  regions supply analysis  business finance sports entertainment health technology travel shopping about us contact us privacy policy advertise press releases terms of service log in page not found  leadership directories products blogs about client support order return home     contact us toll free   broadway suite  new york ny  tel       fax    k street nw suite  washington dc  tel         fax   terms of use  privacy policy  faq  contact us  leadership directories inc anika therapeutics appoints industryrecognized rd executive john w sheets jr phd as chief scientific officer  business wire anika therapeutics appoints industryrecognized rd executive john w sheets jr phd as chief scientific officer anika also announces resignation of coo frank luppino october    pm eastern daylight time bedford massbusiness wireanika therapeutics inc nasdaq anik a leader in products for tissue protection healing and repair based on hyaluronic acid “ha” technology today announced it has appointed john w sheets jr phd as its new chief scientific officer dr sheets joins anika from boston scientific where he was senior vice president corporate research at boston scientific he was responsible for revitalizing product development by establishing new global processes creating worldwide technology strategies and establishing new product sourcing and development networks with a focus on emerging markets dr sheets replaces jingwen kuo phd who is leaving to pursue other opportunities at the end of october in addition to driving anika’s research and development efforts dr sheets is leading the company’s regulatory clinical affairs and engineering functions these previously were overseen by coo frank luppino who is leaving anika at the end of october to pursue other interests mr luppino’s remaining responsibilities are being smoothly transitioned to existing senior executives with operations management reporting directly at the ceo level “john’s appointment as chief scientific officer to oversee our technology and pipeline development provides us with significantly stronger leadership in those critical areas” said charles h sherwood phd anika’s president and ceo “his rd expertise multinational partnership experience and business acumen will be valuable assets as we advance anika’s strategic initiatives and prepare the company for the next level of growth as we welcome john we also would like to thank frank and jingwen for their many contributions to anika’s past success” prior to his work at boston scientific dr sheets was corporate vice president of rd and chief technology officer for bausch and lomb he also served as president of hoya surgical optics and worked for ethicon johnson  johnson alcon laboratories and iolab corporation johnson  johnson in california dr sheets holds a bs a ms and a phd in materials science and engineering from the university of florida gainesville about anika therapeutics inc headquartered in bedford mass anika therapeutics inc develops manufactures and commercializes therapeutic products for tissue protection healing and repair these products are based on hyaluronic acid ha a naturally occurring biocompatible polymer found throughout the body anika’s products range from orthopedicjoint health solutions led by orthovisc® a treatment for osteoarthritis of the knee to surgical aids in the antiadhesion and ophthalmic fields the company also offers aesthetic dermal fillers for the correction of facial wrinkles anika’s italian subsidiary anika therapeutics srl provides complementary ha products in orthopedicjoint health and antiadhesion as well as therapeutics in areas such as advanced wound treatment and ear nose and throat care its regenerative technology advances anika’s vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissues the statements made in this press release which are not statements of historical fact are forwardlooking statements within the meaning of section a of the securities act of  as amended and section e of the securities exchange act of  as amended these statements include but are not limited to those relating to the appointment of john sheets jr phd as anika’s chief scientific officer the departure of jingwen kuo phd as the company’s chief scientific officer the departure of frank luppino as the company’s chief operating officer the nature and successful transition of mr luppino’s responsibilities to existing senior executives and the impact of management changes on its development initiatives and preparation of the company for the next level of growth the companys actual results could differ materially from any anticipated future results performance or achievements described in the forwardlooking statements as a result of a number of factors including i the companys ability to successfully commence andor complete clinical trials of its products on a timely basis or at all obtain preclinical or clinical data to support a premarket approval application or k application or timely file and receive fda or other regulatory approvals or clearances of its products or that such approvals will not be obtained in a timely manner or without the need for additional clinical trials other testing or regulatory submissions as applicable ii the companys research and product development efforts and their relative success including whether the company has any meaningful sales of any new products resulting from such efforts iii the cost effectiveness and efficiency of the company’s clinical studies manufacturing operations and production planning iv the strength of the economies in which the company operates or will be operating as well as the political stability of any of those geographic areas v future determinations by the company to allocate resources to products and in directions not presently contemplated vi the company’s ability to launch monovisc in the us if at all vii the company’s ability to provide an adequate and timely supply of its ophthalmic orthovisc and other products to its customers viii the company’s ability to successfully manage and turnaround anika srl’s business and ix the company’s ability to achieve its stated growth targets certain other factors that might cause the companys actual results to differ materially from those in the forwardlooking statements include those set forth under the headings business risk factors and managements discussion and analysis of financial condition and results of operations in the companys annual report on form k for the year ended december   as well as those described in the companys other press releases and sec filings contacts anika therapeutics inccharles h sherwood phd president and ceosylvia cheung cfo release summary anika therapeutics appoints industryrecognized rd executive john w sheets jr phd as chief scientific officer contacts anika therapeutics inccharles h sherwood phd president and ceosylvia cheung cfo search advanced news search advanced news search log in sign up